Healthcare
Nano-X Imaging Ltd.(NNOX)
Live Price
Offline$1.76
+2.92% today
1Y Change
-67.24%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $120.00M
- Revenue Growth
- +15.4%
- EPS Growth
- -27.5%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Nano-X Imaging Ltd. (NNOX) is a Healthcare stock with a market cap of $120.00M and listed on NASDAQ. The stock last traded around $1.76 and down 67.2% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +15.4%, EPS growth of -27.5%, a dividend yield of 0.0%. What stands out right now is revenue +15.4%, EPS -27.5%, free cash flow -14.3% with operating margin -455.5% and ROIC -38.8%. Valuation already assumes a fairly strong business story at price/sales 9.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NNOX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+15.4% vs +7.6% peer median
Operating Margin
Below sector median
-455.5% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 20, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +15.4% and EPS is at -27.5%, with operating margin around -455.5%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +5.5% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 20, 2026 | โ | +0.9% | -13.7% | -21.1% |
2026 Apr 6, 2026 | +22.1% | -3.0% | +0.4% | -21.1% |
2025 Nov 20, 2025 | -333.3% | +26.4% | +29.9% | -13.3% |
Benchmark Edge
NNOX vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NNOX
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NNOX Max Drawdown
-70.38%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for NNOX and SPY.
Company Overview
Nano-X Imaging Ltd.
NASDAQ Global Market
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
- Leadership
- Erez I. Meltzer
- IPO Date
- Aug 21, 2020
- Employees
- 165
- Street Address
- Communications Center
- Mailing
- Neve Ilan, 9085000
- Region
- Neve Ilan, IL
- Reporting Currency
- USD
- Investor Line
- 972 02 5360360
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 9.2
- Price/Book
- 0.8
Growth
- Revenue
- +15.4%
- EPS
- -27.5%
- Free Cash Flow
- -14.3%
Profitability
- Gross Margin
- -79.4%
- Operating Margin
- -455.5%
- Net Margin
- -576.1%
- ROE
- -47.1%
- ROIC
- -38.8%
Balance Sheet
- Debt/Equity
- 0.06
- Current Ratio
- 3.96
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.